期刊
EXPERT OPINION ON THERAPEUTIC TARGETS
卷 10, 期 4, 页码 573-581出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.10.4.573
关键词
adiponectin; anti-inflammatory; cardioprotection; myocardial infarction
资金
- NHLBI NIH HHS [HL81587, P01 HL081587-02, HL77774, R01 HL077774-02, R01 HL077774, P01 HL081587] Funding Source: Medline
- NIAMS NIH HHS [R01 AR040197-14, R01 AR040197, AR40197] Funding Source: Medline
- NIA NIH HHS [AG15052, R01 AG015052-02, R01 AG015052] Funding Source: Medline
Adiponectin is an adipose tissue-derived plasma protein which has a reduced concentration in subjects with obesity-related diseases. Adiponectin has antidiabetic and anti-inflammatory characteristics, which lead to beneficial actions on various obesity-linked complications. Recent experimental findings have shown that adiponectin contributes to protection against cardiac remodelling after pressure overload and cardiac injury following ischaemia-reperfusion. Thus, adiponectin could emerge as a potential cardioprotective agent for the treatment of several pathological heart conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据